Clinical Trial Update: Micro RNAs to Predict Response to Androgen Deprivation Therapy

View source ↗

Summary

A completed clinical trial evaluated microRNA biomarkers to predict response to androgen deprivation therapy in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Prostate Cancer | Status: COMPLETED